|
- 2016
ARNT2在胃癌中的表达及临床意义
|
Abstract:
[1] | Hankinson O. Why does ARNT2 behave differently from ARNT?[J]. Toxicol Sci, 2008, 103(1): 1-3. |
[2] | Qin XY, Wei F, Yoshinaga J, et al. siRNA-mediated knockdown of aryl hydrocarbon receptor nuclear translocator 2 affects hypoxia-inducible factor-1 regulatory signaling and metabolism in human breast cancer cells[J]. FEBS lett, 2011, 585(20): 3310-3315. |
[3] | Keith B, Adelman DM, Simon MC. Targeted mutation of the murine arylhydrocarbon receptor nuclear translocator 2(Arnt2)gene reveals partial redundancy with Arnt[J]. Proc Natl Acad Sci USA, 2001, 98(12): 6692-6697. |
[4] | Sribudiani Y, Metzger M, Osinga J, et al. Variants in RET associated with Hirschsprungs disease affect binding of transcription factors and gene expression[J]. Gastroenterology, 2011, 140(2): 572-582 e2. doi: 10.1053/j.gastro.2010.10.044. |
[5] | Bersten DC, Sullivan AE, Peet DJ, et al. bHLH-PAS proteins in cancer[J]. Nat Rev Cancer, 2013, 13(12): 827-841. |
[6] | Aitola MH, Pelto-Huikko MT. Expression of Arnt and Arnt2 mRNA in developing murine tissues[J]. J Histochem Cytochem, 2003, 51(1): 41-54. |
[7] | Drutel G, Kathmann M, Heron A, et al. Cloning and selective expression in brain and kidney of ARNT2 homologous to the Ah receptor nuclear translocator(ARNT)[J]. Biochem Biophy Res Commun, 1996, 225(2): 333-339. |
[8] | Martinez V, Kennedy S, Doolan P, et al. Drug metabolism-related genes as potential biomarkers: analysis of expression in normal and tumour breast tissue[J]. Breast Cancer Res Treat, 2008, 110(3): 521-530. |
[9] | Torre LA, Bray F, Siegel RL, et al. Global cancer statistics, 2012[J]. CA Cancer J Clin, 2015, 65(2): 87-108. |
[10] | Qin XY, Wei F, Yoshinaga J, et al. siRNA-mediated knockdown of aryl hydrocarbon receptor nuclear translocator 2 affects hypoxia-inducible factor-1 regulatory signaling and metabolism in human breast cancer cells[J]. FEBS lett, 2011, 585(20): 3310-3315. |
[11] | Hirose K, Morita M, Ema M, et al. cDNA cloning and tissue-specific expression of a novel basic helix-loop-helix/PAS factor(Arnt2)with close sequence similarity to the aryl hydrocarbon receptor nuclear translocator(Arnt)[J]. Mol Cell Biol, 1996, 16(4): 1706-1713. |
[12] | Reyes H, Reisz-Porszasz S, Hankinson O. Identification of the Ah receptor nuclear translocator protein(Arnt)as a component of the DNA binding form of the Ah receptor[J]. Science, 1992, 256(5060): 1193-1195. |
[13] | Li W, Liang Y, Yang B, et al. Downregulation of ARNT2 promotes tumor growth and predicts poor prognosis in human hepatocellular carcinoma[J]. J Gastroenterol Hepatol, 2015, 30(6): 1085-1093. |
[14] | 邹文斌, 李兆申. 中国胃癌发病率及死亡率研究进展[J]. 中国实用内科杂志, 2014, 34(4): 408-415. |
[15] | Garritano S, Inga A, Gemignani F, et al. More targets, more pathways and more clues for mutant p53[J]. Oncogenesis, 2013, 2: e54. doi: 10.1038/oncsis.2013.15. |
[16] | Yang B, Yang E, Liao H, et al. ARNT2 is downregulated and serves as a potential tumor suppressor gene in non-small cell lung cancer[J]. Tumour Biol, 2015, 36(3): 2111-2119. |
[17] | Zudaire E, Cuesta N, Murty V, et al. The aryl hydrocarbon receptor repressor is a putative tumor suppressor gene in multiple human cancers[J]. J Clin Invest, 2008, 118(2): 640-650. |